According to Aspen Pharmacare's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.65416. At the end of 2022 the company had a P/S ratio of 1.40.
Year | P/S ratio | Change |
---|---|---|
2022 | 1.40 | -5.17% |
2021 | 1.47 | -3.8% |
2020 | 1.53 | 75.67% |
2019 | 0.8727 | -56.26% |
2018 | 2.00 | -8.15% |
2017 | 2.17 | -39.77% |
2016 | 3.61 | 23.07% |
2015 | 2.93 | 13.89% |
2014 | 2.57 | -7.61% |
2013 | 2.79 | 73.31% |
2012 | 1.61 | 53.33% |
2011 | 1.05 | -19.74% |
2010 | 1.31 | 37.31% |
2009 | 0.9510 | 0.69% |
2008 | 0.9445 | -19.46% |
2007 | 1.17 | -13.99% |
2006 | 1.36 | 37.81% |
2005 | 0.9894 | 49.41% |
2004 | 0.6622 |